Group 1 - The company announced a share buyback plan, committing HKD 196 million to repurchase 5.5 million shares at a price range of HKD 35.46 to HKD 35.86 per share [1] - Additionally, the company will issue 87,000 shares as part of a share incentive plan for participants, excluding the directors of the issuer [1]

Group 1 - The company, Xiaomi Group-W (01810), announced a share buyback plan, intending to repurchase 5.5 million shares at a total cost of HKD 196 million [1] - The buyback price per share is set between HKD 35.46 and HKD 35.86 [1] - Additionally, the company will issue 87,000 shares as part of a share incentive plan for participants, excluding the directors of the issuer [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 小米集团 (於開曼群島註冊成立以不同投票權控制的有限公司) 呈交日期： 2026年1月20日 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 不同投票權架構公司普通股 | | 股份類別 B | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01810 | 說明 | | | | | | | | 多櫃檯證券代號 | 81810 | RMB 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 ...

Group 1 - The core point of the article is that Xiaomi Group-W (01810.HK) announced a share buyback on January 19, spending HKD 146 million to repurchase 4 million shares [1] Group 2 - The buyback reflects the company's strategy to enhance shareholder value and confidence in its stock performance [1] - The repurchase price indicates the company's commitment to supporting its share price amid market fluctuations [1] - This action may signal to investors that the company believes its shares are undervalued [1]

Group 1 - The company, Xiaomi Group-W (01810), announced a share buyback plan, committing to repurchase 4 million shares at a cost of HKD 146 million [1]

智通财经APP讯，小米集团-W(01810)发布公告，于2026年1月19日，该公司斥资1.46亿港元回购400万 股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 小米集团 (於開曼群島註冊成立以不同投票權控制的有限公司) 呈交日期： 2026年1月19日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 不同投票權架構公司普通股 | | 股份類別 B | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01810 | 說明 | | | | | | | | 多櫃檯證券代號 | 81810 | RMB 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | ...

Group 1 - The core message emphasizes the extreme requirements for the comprehensive capabilities of the three electric technologies (performance, endurance, fast charging, durability) in the new generation SU7 [1] - The SU7 Max achieved a total driving distance of 4264 km in a 24-hour endurance challenge, showcasing its performance and long-range capabilities [2] - The endurance challenge involved continuous driving for 24 hours, including charging time, aimed at providing users with enhanced performance, longer endurance, and a more reliable driving experience [2]

Summary of Key Points Core Viewpoint - On January 16, 44 Hong Kong-listed companies conducted share buybacks, totaling 31.23 million shares and an aggregate amount of HKD 426 million [1]. Group 1: Buyback Details - Xiaomi Group-W repurchased 5.90 million shares for HKD 219.14 million, with a highest price of HKD 37.200 and a lowest price of HKD 37.080, bringing its year-to-date buyback total to HKD 1.45972 billion [2]. - Sunny Optical Technology repurchased 1.13 million shares for HKD 74.89 million, with a highest price of HKD 66.600 and a lowest price of HKD 65.900, accumulating a year-to-date buyback total of HKD 457.32 million [2]. - Xiansheng Pharmaceutical repurchased 4.43 million shares for HKD 51.63 million, with a highest price of HKD 11.773 and a lowest price of HKD 11.520, totaling HKD 93.58 million in year-to-date buybacks [2]. Group 2: Ranking by Buyback Amount - The highest buyback amount on January 16 was from Xiaomi Group-W at HKD 219.14 million, followed by Sunny Optical Technology at HKD 74.89 million [1]. - Other notable buybacks included Xiansheng Pharmaceutical and Juzhibio, with significant amounts as well [1]. Group 3: Ranking by Buyback Volume - Xiaomi Group-W led in buyback volume with 5.90 million shares, followed by Dingdang Health with 5.21 million shares and Xiansheng Pharmaceutical with 4.43 million shares [1].

Group 1 - The core point of the article is that Xiaomi Group-W has been actively repurchasing its shares, with a total of 5.90 million shares bought back on January 16 at a price range of HKD 37.080 to HKD 37.200, amounting to HKD 219 million [2] - The stock has seen a decline of 4.23% during the period of these repurchases, indicating a potential market reaction to the company's buyback strategy [2] - Since January 13, the company has conducted share buybacks for four consecutive days, totaling 17.80 million shares and a cumulative amount of HKD 670 million [2] Group 2 - Year-to-date, Xiaomi Group-W has completed nine buyback transactions, repurchasing a total of 38.35 million shares for a total expenditure of HKD 1.46 billion [3] - A detailed breakdown of the buyback activities shows varying prices and amounts, with the highest buyback price recorded at HKD 39.320 on January 5 [3] - The buyback activities reflect the company's strategy to support its stock price amidst market fluctuations, as evidenced by the stock's performance during the buyback period [3]